New treatment for seizures in newborns with HIE
Treatments studied
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study tests a treatment for seizures in newborn babies who have HIE. It aims to control seizures safely and improve outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby is a newborn (first month of life).
- Diagnosed with moderate or severe HIE (brain injury from lack of oxygen at birth).
- Has shown seizures or abnormal brain wave (EEG) activity within the first 72 hours of life.
- Has not received anti-seizure drugs before starting this trial.
- Seizures are not due to a metabolic cause, pyridoxine (vitamin B6) deficiency, or kidney problems above a specific level.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving both magnesium sulfate and melatonin to newborns with brain injury from lack of oxygen works better than magnesium sulfate alone. The goal is to see if the combination improves recovery and reduces long-term disability.
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This trial tests if giving caffeine to newborns who had low oxygen at birth can help protect their brains. It compares caffeine plus standard care to placebo plus standard care for moderate to severe hypoxic ischemic encephalopathy (HIE).
Hear when a new Neonatal Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.